Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T05:20:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to content or functionality on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:38:40.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.1 and remove v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:19:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI updates introduce glossary show/hide controls and a page revision label (v3.4.0), replacing the previous version. Additionally, several results-status labels were added or removed.
    Difference
    0.3%
    Check dated 2026-01-23T02:58:47.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The revision history shows a minor update: Revision v3.3.4 was added and v3.3.3 was removed, with no impact on study data or documents. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T00:57:15.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Results posting date (Results First Posted 2025-12-12) and enrollment (185) were added, along with a list of participating locations. The page now includes detailed outcome measures and their timeframes (ORR, DOR, DCR, PFS, OS).
    Difference
    5%
    Check dated 2025-12-18T20:00:34.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.